Frankfurt - Delayed Quote EUR

Hims & Hers Health, Inc. (82W.F)

Compare
21.09 +0.25 (+1.20%)
As of 11:43 AM GMT+1. Market Open.
Loading Chart for 82W.F
DELL
  • Previous Close 20.84
  • Open 21.09
  • Bid 20.50 x --
  • Ask 21.30 x --
  • Day's Range 21.09 - 21.09
  • 52 Week Range 7.28 - 28.27
  • Volume 110
  • Avg. Volume 1,487
  • Market Cap (intraday) 4.911B
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) 51.44
  • EPS (TTM) 0.41
  • Earnings Date Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

www.forhims.com

1,046

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 82W.F

View More

Performance Overview: 82W.F

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

82W.F
164.29%
S&P 500
24.05%

1-Year Return

82W.F
211.06%
S&P 500
30.12%

3-Year Return

82W.F
215.72%
S&P 500
25.95%

5-Year Return

82W.F
70.66%
S&P 500
53.71%

Compare To: 82W.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 82W.F

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    4.49B

  • Enterprise Value

    4.26B

  • Trailing P/E

    50.24

  • Forward P/E

    51.28

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.05

  • Price/Book (mrq)

    10.97

  • Enterprise Value/Revenue

    3.64

  • Enterprise Value/EBITDA

    79.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.15%

  • Return on Assets (ttm)

    5.66%

  • Return on Equity (ttm)

    26.35%

  • Revenue (ttm)

    1.24B

  • Net Income Avi to Common (ttm)

    101.26M

  • Diluted EPS (ttm)

    0.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    254.07M

  • Total Debt/Equity (mrq)

    2.58%

  • Levered Free Cash Flow (ttm)

    126.81M

Research Analysis: 82W.F

View More

Company Insights: 82W.F

Research Reports: 82W.F

View More

People Also Watch